Navigation Links
GNS Healthcare Announces Collaboration With Bristol-Myers Squibb
Date:8/10/2011

CAMBRIDGE, Mass., Aug. 10, 2011 /PRNewswire/ -- GNS Healthcare, Inc., (GNS) the leading healthcare analytics company focused on enabling personalized medicine to improve human health, today announced that it has entered into a collaboration with Bristol-Myers Squibb Company (NYSE: BMY) focused on the discovery of novel disease biology and biomarkers in the area of immuno-inflammation.  Utilizing its supercomputer-driven REFS™ (reverse-engineering and forward-simulation) platform, GNS will use clinical and molecular information from a Bristol-Myers Squibb clinical trial to build computer models in a hypothesis-free, unbiased manner that will be simulated to identify key molecular mechanisms. Financial terms of the agreement were not disclosed.

Using patient data comprised of genetic information, gene expression levels, specific blood markers and clinical outcomes researchers will use REFS to construct a comprehensive inflammation disease model directly from the raw data.  The resulting disease model is intended to support virtual clinical trials that will simulate the clinical effect of inhibiting various drug targets and help predict novel molecular targets to combat immuno-inflammation that would be effective for specific types of patients.

“We are pleased to be working with Bristol-Myers Squibb to identify biomarkers in immuno-inflammation,” said Dr. Iya Khalil, Executive Vice President and co-founder of GNS Healthcare. “This is the first step in building a significantly advanced in silico research paradigm that may enable development of new therapies based directly on human data, and address the needs of patients with particular genetics and molecular phenotypes, ultimately enabling the optimization of individualized patient outcomes.” 

About REFS

REFS is comprised of integrated machine learning algori
'/>"/>

SOURCE GNS Healthcare, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. ViroPharma to Present at Three Upcoming Healthcare Conferences
4. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
5. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
6. Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study
7. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
8. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
9. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
10. Iomai CEO to Speak at Acumen BioFin Rodman & Renshaw Annual Healthcare Conference on Monday, Nov. 5
11. Immtech to Present at The Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... 2015 RnRMarketResearch.com adds Syringes ... report that provides an overview of syringes and ... from in-house databases, secondary and primary research. ... products pipeline spread across 124 pages, talking about ... and 5 figures is now available at ...
(Date:7/31/2015)... 2015  Xcelience, a contract development and manufacturing ... a structured cash investment in Powdersize, a ... micronization and powder size classification within the pharmaceutical ... while simultaneously adding a complete set of particle ... "As we continue to build ...
(Date:7/31/2015)... SAN DIEGO , July 31, 2015 /PRNewswire/ ... Co., Ltd. (Headquarters: Tokyo , President ... Therapeutics, Inc. (Headquarters: San Diego, California ... "NASDAQ: HALO") have signed a clinical collaboration agreement to ... "eribulin") in combination with Halozyme,s investigational drug PEGPH20 (PEGylated ...
Breaking Medicine Technology:Syringes and Needles Market Products Pipeline Review 2015 Report 2Syringes and Needles Market Products Pipeline Review 2015 Report 3Syringes and Needles Market Products Pipeline Review 2015 Report 4Syringes and Needles Market Products Pipeline Review 2015 Report 5Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6
... SADDLE BROOK, N.J., Jan. 6, 2011 The FDA,s nod ... options they have to address the problems of sexual dysfunction. ... president of Semprae Laboratories, Inc. The announcement of the approval ... of Flibanserin. Dubbed the "pink pill," the female Viagra equivalent, ...
... COVINGTON, Ky., Jan. 6, 2011 Bexion Pharmaceuticals, LLC announced today ... Board of Directors. Dr. Crawford has had a ... academia. Over ten years of his career were spent at the ... roles and culminating in his appointment as FDA Commissioner. ...
Cached Medicine Technology:What About Us? The State of Women's Sexual Health in Question 2Former FDA Commissioner Joins Bexion Pharmaceuticals Board 2
(Date:8/1/2015)... IN (PRWEB) , ... August 02, 2015 , ... Back ... cause in a school, however, back packs can wreck havoc on a kid's spine. ... carry their supplies to and from school. Make sure you are aware of how ...
(Date:8/1/2015)... ... August 01, 2015 , ... The condition where veins are ... and women often causing pain and discomfort. Those who spend a lot of time ... Northeast Houston Vein Center is doing what it can to create awareness and provide ...
(Date:8/1/2015)... ... 01, 2015 , ... Brig and Lita Hart, icons of the network marketing ... Healthy Home mission with the HOPE Movement of EvolvHealth. In what has been a ... have agreed to join their missions of purpose together to change the course of ...
(Date:8/1/2015)... , ... August 01, 2015 , ... Lume Wellness creators ... is free to download on the Apple AppStore. , The app is designed ... mood, thus acting as a tool to view personal health and use this information ...
(Date:8/1/2015)... ... ... 19, 2015 Phil Valentine – the Executive Director of Connecticut Community for Addiction Recovery (CCAR) ... Springer Mountain and heading north. Since that day, Phil has hiked over 1400 miles in ... friends and family. He visited CCAR and left an inspirational message to his staff: ...
Breaking Medicine News(10 mins):Health News:Local AlignLife Doctor Donates Time to Check Back Packs 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3Health News:Looking for HOPE? Healthy Home Has Evolv’d 2Health News:Looking for HOPE? Healthy Home Has Evolv’d 3Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2
... Market Will Be Driven by Launches, of Disease-Modifying Therapies, According ... ... Resources, WALTHAM, Mass., Sept. 24 Decision ... and,healthcare issues, finds that by 2016 Genentech/Roche,s Lucentis and Eli,Lilly,s ruboxistaurin ...
... Project Pink Campaign Supports Susan G. Komen for the Cure with its ... Celebrity eBay Auction this October, WHAT: Emmy Award-winning journalist and TV ... in Munchkin,s Project Pink Campaign. ... products -- is once again reminding women everywhere "Don,t Duck ...
... the best ways to encourage an individual to ... a personalized approach, according to researchers at Jefferson ... that simple, personalized interventions that guide recipients through ... screening rates in primary care practices. , Ronald ...
... methods significantly raise exam rate, study finds , MONDAY, ... doctors, offices can improve colorectal cancer screening rates, a ... most common kind of cancer and the third leading ... patients don,t experience any symptoms until the disease is ...
... proprietary PhreesiaPad The first free ... DIEGO and NEW YORK, Sept. 24 At ... offer a free patient check-in,solution in the physician,s ... the check-in process, Phreesia delivers fully,interactive relevant health ...
... Meadow Farms world,s first commercial adopter of vaccine ... Bioniche Life,Sciences Inc. (TSX: BNC), a research-based, technology-driven ... E. coli,O157:H7 in cattle has been used for ... Meadow Farms, an Ontario-based producer of premium beef,integrated ...
Cached Medicine News:Health News:Genentech/Roche's Lucentis and Eli Lilly's Ruboxistaurin Will Drive the Diabetic Retinopathy and Nephropathy Drug Markets 2Health News:Cristina Saralegui Joins Celebrities Including Matthew McConaughey, Courteney Cox and Mariska Hargitay to Raise Money for Breast Cancer Research 2Health News:Jefferson researchers find personalized interventions key to improving colon cancer screening rates 2Health News:Doctors' Office Outreach Boosts Colon Cancer Screening 2Health News:Phreesia Launches at DEMOfall 07 2Health News:Phreesia Launches at DEMOfall 07 3Health News:Beef Cattle Vaccinated Against E. coli O157:H7 2Health News:Beef Cattle Vaccinated Against E. coli O157:H7 3
We offer small and large pre-gelled Surface Electrodes suitable for EMG or EGG recordings....
We offer small and large pre-gelled Surface Electrodes suitable for EMG or EGG recordings....
We offer small and large pre-gelled Surface Electrodes suitable for EGG or EMG recordings. Surface Electrodes, Skin Preparation and Conductive Cream complete the setup for a EGG study and are essenti...
We offer small and large pre-gelled Surface Electrodes suitable for EGG or EMG recordings. Surface Electrodes, Skin Preparation and Conductive Cream complete the setup for a EGG study and are essenti...
Medicine Products: